Bingyang Shi

University of Technology Sydney — Australia

Engineering · Physical Sciences

54h-index11.5kcitations209works16.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoplatforms for cancer theranostics(50), RNA Interference and Gene Delivery(49), Nanoparticle-Based Drug Delivery(39), Advanced biosensing and bioanalysis techniques(36), Luminescence and Fluorescent Materials(19)

Publications209 total

Glioblastoma Cell Derived Exosomes as a Potent Vaccine Platform Targeting Primary Brain Cancers and Brain Metastases
ACS Nano·2025· 14 cited
Tumor cell-derived engineered exosome enhances effective immunotherapy for orthotopic glioblastoma and its recurrences
Nano Today·2025· 4 citedOpen Access
MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell
Cell Death Discovery·2025Open Access
Near-infrared theranostics for brain diseases: Design, engineering, and emerging applications
Coordination Chemistry Reviews·2025· 6 cited
A Brain-Targeting NIR-II Polymeric Phototheranostic Nanoplatform toward Orthotopic Drug-Resistant Glioblastoma
Nano Letters·2025· 19 cited
Synapsin III promotes neuronal-like transdifferentiation of glioblastoma stem cells by disrupting JAG1-Notch1 interaction
Neuro-Oncology·2025· 4 citedOpen Access
The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease
Journal of Nephrology·2025Open Access
Advanced nanoparticle engineering for precision therapeutics of brain diseases
Biomaterials·2025· 10 cited
Supramolecular discrimination and diagnosis-guided treatment of intracellular bacteria
Nature Communications·2025· 17 citedOpen Access
Enhanced subacute ischemic stroke treatment via multistage drug delivery system design for combination therapy
Science China Chemistry·2025· 3 cited
CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells
Cell Reports Medicine·2024· 12 citedOpen Access
Application of Bacterial Cellulose Packaging Film Produced via Glycerol-Based In Situ Cultivation for Tomato Preservation
Food and Bioprocess Technology·2024· 3 cited
Targeted protein degradation via cellular trafficking of nanoparticles
Nature Nanotechnology·2024· 50 cited
Blood–Brain Barrier-Penetrative Fluorescent Anticancer Agents Triggering Paraptosis and Ferroptosis for Glioblastoma Therapy
Journal of the American Chemical Society·2024· 45 cited
Synthesis of selective BCL-XL PROTAC and potent antitumor activity in glioblastoma
2024· 1 citedOpen Access
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation
Blood Cancer Journal·2024· 8 citedOpen Access
Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy
Advanced Materials·2024· 21 citedOpen Access
Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma
Nano Today·2024· 23 citedOpen Access
Biomechanical strength of triceps tendon repairs: systematic review and meta-regression analysis of human cadaveric studies
MUSCULOSKELETAL SURGERY·2024· 2 cited
Blood-brain barrier-penetrative fluorescent anticancer agents triggering paraptosis and ferroptosis for glioblastoma therapy
2024· 3 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Meng Zheng(24), Yan Zou(15), Dongya Zhang(11), Wei Tao(10), Roger S. Chung(8), Jinlong Yin(8), Shi‐Zhang Qiao(7), Yibin Wang(6), Yang Liu(5), Fawad Ur Rehman(5), Sumaira Hanif(5), Muhammad Ismail(5), Jiefei Wang(5), Jia Li(4), Haigang Wu(4), Omid C. Farokhzad(4), Guoying Wang(4), Marco Morsch(4), Weimin Ruan(4), Jong Bae Park(4)